First drug approved for treatment of post-partum depression

First drug approved for treatment of post-partum depression

In a recent breakthrough, the Food and Drug Administration (FDA) approved the first drug for the treatment of post-partum depression (PPD). The new drug, brexanolone, will be manufactured by Sage Therapeutics, Inc. and will be marketed under the name Zulresso. This is likely to open floodgates to treatment addressing this debilitating concern which is one of the most common complications post pregnancy.

[…] Read more

No link between depression and birth control contraception, says study

No link between depression and birth control contraception, says study

Over the years, various options of birth control have emerged before women, like pills, patch ring, etc. However, most of them have been widely associated with depression. Many women after taking contraceptive pills have complained about the surge of negative and dark thoughts. However, a new study by researchers at the Ohio State University, published in the journal Contraception, is putting women at comfort by highlighting there is no link between depression and birth control pills, particularly among those using progestin-based contraception.

[…] Read more